Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison--response

Clin Exp Ophthalmol. 2015 Jul;43(5):497-8. doi: 10.1111/ceo.12484.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Dexamethasone / administration & dosage*
  • Female
  • Glucocorticoids / administration & dosage*
  • Humans
  • Macular Edema / drug therapy*
  • Male
  • Retinal Vein Occlusion / drug therapy*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • Dexamethasone